ABSTRACT: The annulus fibrosus (AF) of the intervertebral disc (IVD) has a zonal distribution of phenotypically distinct cells. The outer AF (OAF) cells produce an extracellular matrix (ECM) rich in type I collagen with little proteoglycans, whereas the ECM of the inner AF (IAF) has abundant type II collagen and proteoglycans. The inhomogeneous distribution of the ECM in the AF may reflect the complex mechanical forces that the IVD experiences. A bioengineered AF tissue should recapitulate both the inner and outer zones in order to have proper functionality. The aim of this study is to generate multi-lamellated OAF and IAF tissues with ECM compositions that resemble their zonal origin using polycarbonate urethane (PU) scaffolds. It was observed that supplementation of the media with insulintransferrin-selenium (ITS) and proline yielded tissues with good cellularity. However, IAF cells accumulated only type I collagen, similar to OAF cells. Addition of dexamethasone and sodium pyruvate induced the accumulation of IAF tissues rich in type II collagen and aggrecan, without altering the accumulation of type I collagen in OAF tissues. Dexamethasone stimulated mitochondrial membrane potential in both tissues in the presence of sodium pyruvate, suggesting a relationship between the mitochondrial aerobic respiratory state and dexamethasone signalling during the in vitro-tissue formation by OAF and IAF cells. Inhibition of the glucocorticoid receptor blocked the stimulation of mitochondrial membrane potentials and type II collagen accumulation. In summary, biologically distinct multilamellated OAF and IAF tissues can be generated, which will facilitate advancement towards the goal of engineering a biological IVD replacement. ß
The intervertebral disc (IVD) is composed of nucleus pulposus (NP), surrounded by multi-lamellated annulus fibrosus (AF) and interfaced to the adjacent vertebral bodies through the cartilage endplate. The AF is anisotropic by nature, with cells and collagen fibrils oriented at approximately 60˚from the spinal column. 1 The lamellae are organized in an angle-ply fashion and form an integrated tissue whose function is dependent on the inhomogeneous distribution of different collagens types, proteoglycans, translamellar, and interlamellar elements, all of which have been shown to permit different degrees of motion and allow the tissue to resist changing strains. [1] [2] [3] [4] Under loading, the interlamellar adhesion enables the shear strains between individual lamella and resists interlamellar slippage or separation, maintaining the cohesiveness of the AF. 3, 4 Image-based finite element modeling showed a significant reduction in the compression stiffness of the IVD if interlamellar slippage or separation was allowed, suggesting an important role for lamellar adhesion and integration towards protecting the IVD from mechanical failure. 5 The extracellular matrix (ECM) of inner annulus fibrosus (IAF) has admixed type II collagen, versican and aggrecan while the ECM of outer annulus fibrosus (OAF) is composed predominately of type I collagen. 6 Interfaced to the NP without a distinct boundary, 7 the IAF with its abundant proteoglycan content confers the swelling pressure required for fibre elasticity, 8 and resistance against internal compressive, 9 radial and shear stresses. 10 Under compressive loading, the IAF and NP experience high intradiscal pressures, while in degenerate IVDs the pressures are imposed onto the OAF instead. 11 This has been observed to result in uneven distribution of compressive loads as well as localized regions of high shear stresses, predisposing the disc to degeneration. 12 Chronic neck or low back pain can be associated with degenerative disc disease, and has been reported to cost the healthcare system over $110 billion USD. 13, 14 As there are no current treatments that can fully restore the functionality of the IVD, engineering a biological replacement which can be used to replace a native disc, in part or in its entirety, is being intensively investigated. While the generation of NP tissues alone with proper compressive properties has been successfully achieved using scaffold-free methods or hydrogels, 15, 16 the engineering of the AF has been more challenging.
Studies investigating the bioengineering of OAF have employed different strategies which focus on the features of the native AF tissue, such as using lamellar biomaterials with aligned anisotropic fibres, and the use of appropriate cell sources. [17] [18] [19] [20] [21] However, little attention has been paid to developing the IAF component, even though this tissue is likely required to engineer a mechanically functional IVD that will have sufficient strength to absorb the high levels of internal strains. There have been a few studies which have reported the generation of tissues with the molecular composition of the native IAF-particularly the accumulation of type II collagen. Several studies have shown the presence of type II collagen in in vitrogenerated AF tissues. In one study rabbit AF cells were grown in an atelocollagen honeycomb-shaped scaffold (ACHMS-scaffold), using transforming growth factor b (TGF-b)-supplemented media, while in another study human nasal chondrocytes were cultured in chondroitin sulphate-crosslinked silk fibroin. 19, 21 Studies using cells obtained from either human or bovine AF, and cultured in either collagen-enriched fibrin gels or rat tail type I collagen gels showed the accumulation of type II collagen after implantation into the subcutaneous tissue of athymic mice or the disc space of rats respectively. 17, 20 However, none of these studies have established the conditions that allow for the simultaneous formation of OAF and IAF tissues under the same culture conditions as will be required when engineering a biological disc replacement. Although the Nicoll group showed that OAF and IAF cells isolated separately from bovine IVDs showed loss of phenotypic differences when cultured in a 3D environment using polyester fibre mesh in media supplemented with 10% fetal bovine serum (FBS), our group did not observe this loss. 22 In contrast, OAF and IAF cells grown as a monolayer on a single biodegradable nanofibrous polycarbonate polyurethane (PU) scaffold in the presence of 20% FBS were able to maintain their distinctive phenotype features. 6 Thus it was hypothesized that compositionally distinct multilamellated OAF and IAF tissues can be generated under identical culture conditions in vitro. Identifying such a culture protocol will facilitate the generation of a biological IVD replacement, the composition of which will recapitulate the native tissues.
MATERIALS AND METHODS

Fabrication of Multi-Lamellated Polycarbonate Urethane (PU) Constructs
The synthesis of a base polymer PU was generated from the reaction of poly(1,6-hexyl 1,2-ethyl carbonate)diol, 1,6-hexane diisocyanate and 1,4-butanediol in N,N-dimethylacetamide (DMAC) solvent at a temperature between 60˚C to 70˚C. 23 Anionic dihydroxy oligomer (ADO) was synthesized from the reaction of polytetramethylene oxide, hydroxyethylmethacrylate (HEMA), and lysine diisocyanate in DMAC overnight at a temperature between 50˚C to 60˚C, followed by the hydrolysis of lysine and HEMA ester groups and the formation of hydroxyl and carboxylate groups. ADO was added to PU at a concentration of 0.15% by weight relative to the PU. Nanofibrous PU was fabricated by electrospinning onto a rotating mandrel at 1200 rpm and an applied potential difference of 20,000V. The scaffold was dried in an Isotemp Vacuum Oven (Model 280A, Fisher Scientific, Pittsburgh, PA) overnight at 45˚C and was sterilized by gamma irradiation (2.5 MRad). The membrane was precoated with fibronectin (20 mg/ml filter-sterilized phosphate buffered saline without Ca 2þ and Mg 2þ (PBS-/-), F0895, Sigma-Aldrich, St. Louis, MO) overnight at 4˚C. 6 Cell Isolation and Culture The intervertebral discs were aseptically removed from bovine caudal spines (9-12 months of age) and placed in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 1Â Antibiotic-Antimycotic (Invitrogen, Carlsbad, CA). OAF and IAF tissues were dissected out separately from the discs. Each tissue type was cut into pieces and separately digested for 90 min in 0.3% protease Type XIV (SigmaAldrich), followed by 0.2% collagenase A for OAF and 0.1% collagenase A (Sigma-Aldrich) for IAF for 15 h at 37˚C. Cells were filtered using a sterile mesh, and washed three times with DMEM supplemented with 5% FBS. To prevent the cross-contamination of cells from the OAF and IAF, the transition zone between the two zones was not sampled. Dissection accuracy was confirmed by submission of random tissue samples for histological assessment. As well, following cell isolation, the primary cells were subjected to quantitative PCR analysis which confirmed differential expression of the ECM genes type I collagen (COL1A1), type II collagen (COL2A1), and aggrecan (ACAN) further verifying the isolation of enriched OAF and IAF cell populations (Fig. S1 ). Only primary cells were used in this study.
The fibronectin-coated PU was cut into strips (50 mm in length, 3 mm in width) under sterile conditions. Each multilamellated PU construct was generated by rolling one strip of PU around Tygon 1 3350 tubing (Saint-Gobain, Akron, OH) and secured by pinning a 22G BD SafetyGlide TM sterile needle (BD Biosciences, Franklin Lakes, NJ) through the layers of the scaffolds and the tubing. The nanofibres were aligned uniformly along the circumference of the multilamellated PU constructs. A total of 12 constructs were placed within each spinner flask ( Fig. 1A and B) . 15 Â 10 6 OAF cells or IAF cells suspended in 5 ml of 5% DMEM and were added into each spinner flask containing 30 ml of DMEM supplemented with FBS (Wisent Bioproducts, StBruno, Quebec, Canada) at various concentrations ranging from 5% to 20%, as specified in the results section. L-Proline (40 mg/ml, Sigma-Aldrich), ITS (1% (final concentration: 6.25 mg/ml insulin, 6.25 mg/ml transferrin, 6.25 ng/mL selenous acid, 1.25 mg/mL BSA, 5.35 mg/mL linoleic acid), Corning 1 ITSþ Premix Universal Supplement, BD Biosciences, Franklin Lakes, NJ, USA), dexamethasone (0.1 mM, SigmaAldrich) and sodium pyruvate (1 mM, Thermofisher Scientific, Waltham, MA) were added to select cultures. The constructs were cultured at 30 rpm for up to 2 weeks. Ascorbic acid (final concentration 100 mg/ml, Sigma-Aldrich) was added on the 3rd day of culture and replaced with each media change. 75% of the media was changed every 2 or 3 days.
Assessment of Total DNA, Sulphated Glycosaminoglycan, and Collagen Contents Cultures harvested at various times were digested with papain (40 ml/ml; in digestion buffer containing 20 mM ammonium acetate, 1 mM EDTA and 2 mM DTT at pH 6.2; Sigma-Aldrich) for 48 h at 65˚C. DNA content was determined using Hoechst 33258 dye binding assay (Polysciences, Warrington, PA) and fluorometry (excitation wavelength 365 nm, emission wavelength 458 nm) as described previously. 24 Sulphated glycosaminoglycans were determined using dimethylmethylene blue binding assay (Polysciences) and spectrophotometry (525 nm) as described previously. 24 Collagen content was determined by quantifying the amount of hydroxyproline content. Papain digests were acid-hydro-
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lyzed and quantified for OH-proline content by chloramine-T/ Erlich's assay and spectrophotometry (560 nm) as previously described. 24 Inhibition of Dexamethasone IAF tissues were removed from spinner flasks after 7 days of culture and placed into single wells of a 12-well plate and incubated with 3 ml of serum-free media containing L-Proline (40 mg/ml), ITS (1%), dexamethasone (0.1 mM), sodium pyruvate (1 mM), and ascorbic acid (100 mg/ml) in the presence or absence of mifepristone (0, 12.5, 25, 50, or 100 mM; M8046, Sigma-Aldrich). Mifepristone binds the glucocorticoid receptor (GR) and is a competitive antagonist to dexamethasone. 25 Tissues were cultured for another 7 days statically and media was changed every 2 days.
Staining for Membrane Potential Activity in the Mitochondria
MitoTracker 1 Red CM-H2XRos (Thermofisher Scientific), a nonfluorescent cell-permeable dye that sequesters in the intermembrane space of mitochondria with active membrane potential and when oxidized becomes fluorescent, was resuspended in DMSO at a stock concentration of 1 mM. Multi-lamellated PU constructs cultured with OAF or IAF cells were removed from culture and rinsed with serum-free media prior to incubation with MitoTracker 1 Red CM-H2XRos (1:5000 dilution in DMEM containing 1% ITS, 0.1 mM dexamethasone and 1 mM sodium pyruvate) for 3 h in a humidified tissue culture incubator at 37˚C in the dark. Samples fixed with methanol for 1 h prior to MitoTracker 1 Red CM-H2XRos incubation were used as the negative control to induce cell death and absence of mitochondrial activity. All samples were washed with PBS-/-, fixed in 10% formalin for an hour and infiltrated with 30% sucrose overnight. The samples were embedded in O.C.T. compound and cryosectioned while protected from light. Nuclei were counterstained with DAPI, and sections were imaged using fluorescent microscopy (Ex/Em ¼ 579 nm/599 nm). Only the tissues on the inner and outer surface of the multi-lamellated PU constructs were examined as the dye could not consistently penetrate through the full thickness of the PU scaffold. The MitoTracker 1 Red CM-H2XRos fluorescence from the generated images were analyzed using ImageJ software. The images were split into separate colour channels and the stained cells were individually quantified for the pixel density as an output for fluorescence intensity. The fluorescence level per stained cell was averaged from at least eight image fields captured at 60Â magnification per sample with at least 15 cells counted per image.
Statistical Analysis
Each independent experiment was repeated at least four times (N ¼ 4-7) and each condition was repeated in duplicate in each experimental group. To obtain sufficient cells OAF and IAF tissues from at least two spines were pooled for each experiment. Results are expressed as mean AE 95% confidence intervals. One-way or two-way analysis of variance (ANOVA) with the Tukey's post-hoc test was used to evaluate significance. Significance was assigned at p < 0.05.
Methods used for histological processing, gene expression analysis, immunostaining, and Western blot analysis are described in detail in the Supplementary Materials.
RESULTS
Supplementation of Media With ITS and Proline Facilitated Tissue Formation by AF Cells Grown on Multi-Lamellated PU Scaffolds
The medium conditions used to grow IAF and OAF cells as a monolayer on a single layer of PU scaffold (DMEM supplemented with 20% FBS and ascorbic acid) 6 did not result in consistent tissue formation in multi-lamellated PU scaffolds (Fig. 1C) . Histological examination showed that while there were cells attached to the PU lamella, little tissue formed (Fig. 1C) . The supplementation of 1% ITS and proline (in addition to 20% FBS) resulted in tissue formation, as confirmed by histological examination (Fig. 1C) . IAF and OAF cells grown in the supplemented media had significantly greater DNA content compared to cells grown in control medium (Fig. 1D) . To determine if the concentration of serum influenced tissue formation by AF cells, they were grown in the presence of ITS and proline supplemented with various concentrations of serum (5%, 10%, and 20%). Histological examination showed that the OAF or IAF tissues cultured with the different serum concentrations in the multi-lamellated PU constructs were morphologically similar and showed spindle shaped cells embedded in the ECM between the lamella, on the outer aspect of the last layer, and on the inner aspect of the innermost layer ( Fig. 2A) . There was no significant difference in cellularities between tissues formed by either IAF or OAF cells at serum concentrations of 5%, 10%, or 20% (Fig. 2B) . The amounts of sulphated glycosaminoglycans or hydroxyproline accumulated did not change between serum concentrations when normalized to the quantified DNA content per sample (Fig. S2 ). Therefore, a serum concentration of 10% was used for all further experiments. At this serum concentration, the DNA contents of the OAF and IAF tissues harvested 24 h after cell seeding showed no significant differences between the ITS and proline supplemented media and control media, indicating that ITS and proline supplementation did not affect seeding efficiency (Fig. S3) . The supplementation of ITS and proline resulted in significant increases in accumulated DNA content over time compared to the control media for both tissues (Fig. S3) , confirming that ITS and proline facilitated tissue formation with time.
To determine if the AF cells retained their phenotype under these media conditions, sections were stained with antibodies reactive with either type I or type II collagen or aggrecan, the major macromolecules present in the AF ECM. Type I collagen, orientated parallel to the alignment of PU nanofibres, was present in the multi-lamellated OAF tissues with no type II collagen or aggrecan detected by immunohistochemical staining, suggesting that the phenotype of OAF cells was maintained (Fig. 2C) . Multi-lamellated IAF, similar to OAF tissue, showed only the presence of type I collagen, indicating that IAF cells had lost their phenotype (Fig. 2C) .
Medium Supplementation With Sodium Pyruvate and Dexamethasone Restored IAF Phenotype
In a previous study, chondrocytes that were dedifferentiated through passaging were able to reacquire the ability to form chondrogenic tissue when the media was supplemented with dexamethasone (DEX) and sodium pyruvate (SP). 26 Given the presence of both aggrecan and type II collagen in the ECM of both cartilage and IAF tissues, the following experiments examined whether these molecules could also prevent the loss of IAF phenotype when grown as a multilamellated tissue. OAF cells were grown under identical conditions to determine if these cells would retain their phenotype, as the simultaneous co-culture of these tissues would be a condition required when bioengineering an IVD. The supplementation of SP, DEX, or SP þ DEX did not affect cell seeding efficiency when comparing the DNA content at 24 h post seeding (Fig. S4) . IAF tissues showed an increase in DNA content over time in all medium conditions except when DEX þ SP were present (Fig. S4) . After 2 weeks in culture, IAF tissues cultured in DEX þ SP showed significantly decreased DNA content when compared to the other conditions, but they had accumulated significantly greater amounts of hydroxyproline and sulphated glycosaminoglycans (Fig. 3) . The tissues formed in the presence of DEX supplementation showed small foci of type II collagen and aggrecan as shown by immunostaining, whereas the tissues formed in the presence of DEX þ SP showed abundant immunostaining for type II collagen and aggrecan that were uniformly distributed across the multiple lamellae (Fig. 4B) .
Similar to IAF cells, OAF cell seeding efficiency did not alter with different medium conditions and showed an increase in DNA content over time (Fig. S4) . Although there was no difference in accumulated sulphated glycosaminoglycan content, the tissues cul- Ã indicates PU scaffold.
TOWARDS ENGINEERING MULTI-LAMELLATED OUTER AND INNER ANNULUS FIBROSUS TISSUES
tured in DEX alone had significantly lower cellularity and less hydroxyproline compared to the tissues cultured in the presence of DEX þ SP (the optimal media for IAF cells) (Fig. 3) . Immunostaining demonstrated only the presence of type I collagen in all media conditions (Fig. 4A ), suggesting the cells had maintained their phenotype.
Dexamethasone Increased Mitochondrial Membrane Potential in the Presence of Sodium Pyruvate
As DEX þ SP did not alter the composition of multilamellated tissues produced by OAF cells (only type I collagen detected) but restored the accumulation of type II collagen and aggrecan by IAF cells, further studies were conducted to investigate the mechanism(s) that might be involved in regulating this effect. Pyruvate is known to be oxidized to carbon dioxide in the mitochondria during aerobic respiration, resulting in high-energy electrons that generate a voltage gradient (membrane potential) across the inner mitochondrial membrane to drive ATP synthesis. 27 To determine if mitochondria were activated by these supplements to the media, OAF and IAF tissues were incubated with MitoTracker Red CMH 2 XRos. Both OAF and IAF cells showed no significant increase in mitochondrial membrane potentials when pyruvate or DEX alone supplemented media was compared to control (indicated by the quantified MitoTracker CMH 2 XRos fluorescence signal per cell) (Fig. 5) . The mitochondrial membrane potentials for both OAF and IAF cells were significantly increased when pyruvate was supplemented in the presence of dexamethasone (DEX þ SP) (Fig. 5) .
The Accumulation of Type II Collagen and the Increase in Mitochondrial Membrane Potentials in IAF Tissues Were Dependent on Glucocorticoid Receptor Activation
To further understand how DEX þ SP induced type II collagen accumulation in IAF tissues, IAF cells were incubated in the absence or presence of various concentrations of mifepristone (RU486). Western blot analysis of extracted collagens and semi-quantification by densitometry confirmed that the amount of type II collagen was significantly decreased in 2-week-old multi-lamellated IAF tissues after 7 days of culture with 50 mM mifepristone ( Fig. 6A and B) . GR inhibition by 50 mM mifepristone not only decreased immunoreactivity for type II collagen (Fig. 6C ) and the amount of hydroxyproline significantly (Fig. S5) but also resulted in a significant loss of mitochondrial membrane potential (Fig. 7) . Type I collagen was not detected in control or treated tissues (Fig. S5) . The accumulation of DNA, aggrecan and sulphated glycosaminoglycans were not affected by GR inhibition (Fig. S5) .
DISCUSSION
This study demonstrated that growth in a spinner bioreactor in media supplemented with serum, 1% ITS, proline, dexamethasone and pyruvate improved the tissue formation of the multi-lamellated OAF tissues. It also permitted the maintenance of the IAFphenotype and the accumulation of appropriate ECM in multilamellated IAF tissues without altering the ECM composition of OAF tissues. The addition of ITS and proline resulted in increased tissue cellularity. Furthermore it appears that the critical media components are dexamethasone and sodium pyruvate as they were both necessary for the cells in IAF tissues to resemble their native phenotype. The addition of these molecules induced type II collagen and aggrecan accumulation by IAF cells as determined by immunostaining, western blot and biochemical quantification. Dexamethasone and sodium pyruvate appeared to increase the aerobic respiratory activity of mitochondria in a cooperative manner. Particularly for IAF cells, the inhibition of dexamethasone by mifepristone decreased type II collagen accumulation and 
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mitochondrial activity but did not result in changes in the accumulation of aggrecan. Thus it is possible to generate multi-lamellated OAF and IAF tissues in vitro that are distinct in ECM composition which, based on their physiological functions, will be critical for the tissue engineering of a biological disc replacement that mimics the native tissue. The loss of IAF cells' ability to form an ECM rich in aggrecan and type II collagen on multi-lamellar aligned nanofibrous PU scaffold was unexpected given that the retention of phenotype was not a problem for IAF cells grown on a single scaffold layer. 6 There are three possible explanations for this. Firstly, the use of the multi-lamellar scaffold in the spinner bioreactor may have contributed to this observed phenotype change. Although this culture system is known to improve tissue formation by providing shear flow which promotes the convective transport of nutrients, 28 it has also been shown to negatively affect matrix accumulation. 29 For example, gene expression of type II collagen aggrecan and proteoglycan synthesis by chondrocytes has been documented to decrease under high perfusion rates and shear stress when grown in a spinner bioreactor. 29 Secondly, the 3D organization and/or tension applied by the scaffold may affect AF cell phenotype. For example the Nicoll group found that when cultured in 3D scaffolds, such as alginate and poly(lactide-co-glycolide) mesh, the phenotypic differentiation between OAF and IAF cells was lost. 22 It was shown in a previous study by our group that OAF cells respond at the molecular and cellular level to the changes in scaffold tension. 30 The single-layered PU scaffolds employed in previous studies were confined within custom-fabricated holders to secure a 2D culture surface, an approach which applied tension along the direction of the fibre orientation. 30 The elastic modulus of the single-layered PU scaffolds were reported to have an elastic modulus of 8 MPa, whereas the elastic modulus of PU scaffolds without the applied tension (similar to the multilamellated PU constructs used in this study) was reported to be 3 MPa. 30 A positive correlation between biomaterial stiffness and cell proliferation has been shown by others for rat AF cells. 31 The lower elastic modulus and/or lack of applied tension in the multilamellated PU may account for the lack of tissue formation by reducing cell proliferation in the multilamellated PU, which was restored by ITS and proline supplementation. Thirdly, cell proliferation may have contributed to the observations. Chou et al. showed that IAF and OAF cells when serially passaged, a condition that favours proliferation, lost their phenotype. 32 The increase in DNA accumulation by ITS and proline supplementation may account for the loss of IAF cell phenotype in the multi-lamellated PU constructs. Interestingly, this could be compensated for by supplementing the media with dexamethasone and pyruvate. However, there are other confounding factors such as the stiffness of the culture dish and the effect of repeated trypsinization on cells that may have contributed to the loss of phenotype during passaging. 33, 34 These confounding factors were not applicable in this study. Further investigation will be required to understand the critical regulatory factor(s) controlling cell proliferation versus maintaining IAF phenotype.
The addition of ITS and proline to the culture media promoted cell proliferation as DNA content increased significantly in these cultures, both for IAF and OAF cells. Both insulin and proline can affect cell proliferation. Insulin has been shown to activate the phosphoinositide 3-kinase/Akt signalling pathway. 26 Induction of the Atk signalling pathway through phosphorylation has been reported to increase the rate of cell proliferation by NP and total AF cells in vitro. 35 Proline is also known to increase DNA synthesis. 36 It is thought to regulate DNA synthesis by serving as a precursor to polyamines, which chemically modifies eukaryotic initiation factor 5A (eIF5A), increasing ribosomal aggregation, protein synthesis and proliferation. 37, 38 The lack of a serum concentration effect on cell proliferation was likely due to the presence of ITS as it has been shown that the decrease in proliferation by serum reduction could be compensated with the introduction of ITS. 39, 40 Dexamethasone has a variety of transcriptional effects, examples of which includes the induction of SOX9 gene expression that regulates COL2A1 and aggrecan gene expression in chondrocytes. 26, 41 However, other factors contributed to IAF phenotype restoration as dexamethasone alone was not sufficient and pyruvate was also required to restore type II collagen and aggrecan accumulation by IAF cells. The increase in mitochondrial membrane potential (as visualized by an increase in MitoTracker 1 Red CMH2XRos fluorescence) in the multi-lamellated OAF and IAF tissues was observed when both dexamethasone and pyruvate were provided, suggesting a mechanistic link between pyruvate metabolism and dexamethasone signalling in OAF and IAF cells. The electron transport chain (ETC) transfers electrons harvested from the oxidation of pyruvate, generating membrane potentials across the inner mitochondrial membrane, which in turn drives ATP synthesis, and reducing oxygen into reactive oxygen species (such as superoxide anions). 42 The process of ATP synthesis driven by the mitochondrial membrane potential is known as oxidative phosphorylation (OXPHOS). Fluorescence of MitoTracker 1 Red CM-H2XRos indicates activated membrane potential as the reactive oxygen species generated by OXPHOS converts the dye into its fluorescent form. In this study, OXPHOS was not directly assessed but the observation that MitoTracker 1 Red CM-H2XRos fluorescence intensity increased is indicative of higher membrane potentials. Dexamethasone is known to regulate the expression of mitochondrial genes involved in OXPHOS, increasing oxygen consumption and mitochondrial membrane potential. 43, 44 A relationship between dexamethasone treatment and increased membrane potential was observed for IAF cells in this study as the inhibition of the dexamethasone target, the glucocorticoid receptor (GR), resulted in decreased mitochondrial membrane potentials.
A previous study showed that mifepristone reduced the dexamethasone-mediated accumulation of type II collagen by human mesenchymal stromal cells in pellet cultures in the presence of ITS, proline and pyruvate through unknown mechanisms. 45 Few studies have yet to demonstrate a direct relationship between extracellular matrix accumulation and mitochondrial activity. However, ATP has been reported to enhance proteoglycan and collagen accumulation by IVD cells and chondrocytes when supplied exogenously. 46, 47 Furthermore, OXPHOS dysfunction has also been shown to increase the protein levels of matrix metalloproteinase 1 (MMP-1) and decrease the protein levels of tissue inhibitor of the metalloproteinases 1 (TIMP1) in osteosarcoma cells, suggesting that impaired mitochondrial membrane potential can be associated with extracellular matrix degradation. 48 In osteoarthritic cartilage explants, the mitochondrial membrane depolarization and ATP depletion were associated with increased levels of lipid inflammatory mediators prostaglandins and leukotrienes. 49 Furthermore, dexamethasone was shown to decrease the gene expression of collagen-cleaving matrix metalloproteinase 1 (MMP-1) and matrix metalloproteinase (MMP-3) but not aggrencanases ADAMTS-4 and -5 (a disintegrin and metalloproteinase with thrombospondin motifs-4 and -5) in bovine articular chondrocytes and cartilage explants. 50, 51 Therefore, the loss of accumulated type II collagen but not aggrecan induced by mifepristone inhibition may be a result of increased Figure 8 . Proposed mechanism of action of dexamethasone and pyruvate in the regeneration of multilamellated OAF and IAF tissues. The mitochondrial membrane potential is activated by the co-supplementation of pyruvate and dexamethasone. Dexamethasone binds to glucocorticoid receptor (GR), thereby translocating the activated GR into the mitochondria and upregulating the machinery required for OXPHOS, while pyruvate serves as the electron donor for the electron transport chain. Ligand-bound GR also translocates into the nucleus, and under the activated OXPHOS, type II collagen and aggrecan were accumulated in multi-lamellated IAF tissues while the accumulation of type I collagen in OAF tissues was not altered.
expression of collagenase but not aggrecanase, potentially mediated by impaired mitochondrial activity. Further studies will be required to determine whether the change in collagen type accumulated is a result of increased degradation or a change in cell phenotype.
The different responses of OAF and IAF cells to the presence of dexamethasone and pyruvate provides further evidence to support the inherent distinctive phenotypes of the two cell types and thereby demonstrating the need to address them as distinct tissue types. 6 As the native IAF tissue shares some compositional similarities to the articular cartilage tissue and is distinct from the native OAF tissues, the effect of dexamethasone in the presence of pyruvate on IAF cells may be similar to the mechanism of action shown for chondrocytes. For that cell type SOX9 gene expression was induced, upregulating COL2A1 and aggrecan expression. 41 The restoration of the phenotypic differentiation for IAF tissues by dexamethasone was dependent on the presence of pyruvate, indicating a significant role for small metabolites in the modulation of cell phenotypes. The proposed mechanistic roles played by dexamethasone and pyruvate in the regeneration of multi-lamellated OAF and IAF tissues are depicted in Figure 8 . Interestingly, during disc degeneration, the diffusion of metabolites into the avascular IVD is impaired as the cartilage endplate calcifies. The findings of this study suggests that impaired diffusion of metabolites such as pyruvate may in part contribute to disc degeneration, as an appropriate level of mitochondrial activity is necessary for the production of appropriate extracellular matrix molecules. In summary, a culture condition was identified that allowed the production of IAF-like and OAF-like multi-lamellated tissues by bovine OAF and IAF cells. Further study is required to confirm that OAF and IAF cells derived from human AF tissues will respond similarly, and form IAF and OAF multi-lamellated tissues which will be required for bioengineering of the IVD.
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